BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stronati L, Palone F, Negroni A, Colantoni E, Mancuso AB, Cucchiara S, Cesi V, Isoldi S, Vitali R. Dipotassium Glycyrrhizate Improves Intestinal Mucosal Healing by Modulating Extracellular Matrix Remodeling Genes and Restoring Epithelial Barrier Functions. Front Immunol 2019;10:939. [PMID: 31105713 DOI: 10.3389/fimmu.2019.00939] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Leite CDS, Bonafé GA, Carvalho Santos J, Martinez CAR, Ortega MM, Ribeiro ML. The Anti-Inflammatory Properties of Licorice (Glycyrrhiza glabra)-Derived Compounds in Intestinal Disorders. Int J Mol Sci 2022;23:4121. [PMID: 35456938 DOI: 10.3390/ijms23084121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Dassamiour S, Bensaad MS, Hambaba L, Haba H, Nouicer F, Kadrine N, Hachemi M, Sami R, Al-mushhin AAM, Aljahani AH. Wound Healing Capacity of the n-Butanolic Extract of Centaurea tougourensis Boiss. & Reut. sci adv mater 2022;14:430-9. [DOI: 10.1166/sam.2022.4220] [Reference Citation Analysis]
3 Fiaschini N, Negroni A, Palone F, Vitali R, Colantoni E, Laudadio I, Mancuso M, Cucchiara S, Stronati L. Colonic inflammation accelerates the progression of liver disease: A protective role of dipotassium glycyrrhizate. Dig Liver Dis 2021:S1590-8658(21)00854-9. [PMID: 34903499 DOI: 10.1016/j.dld.2021.11.015] [Reference Citation Analysis]
4 Li R, Cheng L, Wang Q, Zhou L. Comparative Transcriptomic Analysis Reveals the Immunosuppressive Targets of Mesalazine in Dextran Sulfate Sodium-Induced Ulcerative Colitis. Front Genet 2021;12:698983. [PMID: 34456974 DOI: 10.3389/fgene.2021.698983] [Reference Citation Analysis]
5 Tran A, Scholtes C, Songane M, Champagne C, Galarneau L, Levasseur MP, Fodil N, Dufour CR, Giguère V, Saleh M. Estrogen-related receptor alpha (ERRα) is a key regulator of intestinal homeostasis and protects against colitis. Sci Rep 2021;11:15073. [PMID: 34302001 DOI: 10.1038/s41598-021-94499-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Duan L, Cheng S, Li L, Liu Y, Wang D, Liu G. Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease. Front Pharmacol 2021;12:684486. [PMID: 34335253 DOI: 10.3389/fphar.2021.684486] [Reference Citation Analysis]
7 Kong C, Yan X, Liu Y, Huang L, Zhu Y, He J, Gao R, Kalady MF, Goel A, Qin H, Ma Y. Ketogenic diet alleviates colitis by reduction of colonic group 3 innate lymphoid cells through altering gut microbiome. Signal Transduct Target Ther 2021;6:154. [PMID: 33888680 DOI: 10.1038/s41392-021-00549-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang Y, Thanou M, Vllasaliu D. Exploiting disease-induced changes for targeted oral delivery of biologics and nanomedicines in inflammatory bowel disease. Eur J Pharm Biopharm 2020;155:128-38. [PMID: 32853696 DOI: 10.1016/j.ejpb.2020.08.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Shi YJ, Hu SJ, Zhao QQ, Liu XS, Liu C, Wang H. Toll-like receptor 4 (TLR4) deficiency aggravates dextran sulfate sodium (DSS)-induced intestinal injury by down-regulating IL6, CCL2 and CSF3. Ann Transl Med 2019;7:713. [PMID: 32042729 DOI: 10.21037/atm.2019.12.28] [Cited by in Crossref: 10] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
10 Yang C, Merlin D. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives. Int J Nanomedicine 2019;14:8875-89. [PMID: 32009785 DOI: 10.2147/IJN.S210315] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
11 Mortensen JH, Lindholm M, Langholm LL, Kjeldsen J, Bay-Jensen AC, Karsdal MA, Manon-Jensen T. The intestinal tissue homeostasis - the role of extracellular matrix remodeling in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2019;13:977-93. [PMID: 31587588 DOI: 10.1080/17474124.2019.1673729] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]